Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innoture is a UK healthcare technology and medical device company developing, manufacturing, and commercialising customised microneedle patches and related transdermal delivery systems. Its platform is designed to improve patient experience, treatment performance, cost-effectiveness, and access by enabling minimally painful delivery of medicines, vaccines, and aesthetic products through the skin. The company works with pharmaceutical partners to tailor microneedle designs for specific active pharmaceutical ingredients and applications. Innoture appears to operate as a platform and product-enabling company rather than a single-asset therapeutics developer, with activity spanning vaccines, pain relief, cosmetics, and broader drug delivery. It reports prior human clinical trial experience and emphasizes scalable manufacturing enabled by proprietary patented production technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innoture Medical Technology.